WeVote
Log In

Bill

Bill

A 184

Requires epinephrine auto-injector devices at children's overnight, summer day and traveling summer camps

2025 Regular Session Introduced by Linda Rosenthal

New York would require children's overnight and summer camps to stock epinephrine auto-injectors for emergency allergic reaction response.

PRINT NUMBER 184A
0
WeVote Research Nonpartisan
Bill Summary · A 184

Legislative bill overview

Bill A 184 mandates that children's overnight camps, summer day camps, and traveling summer camps operating in New York must have epinephrine auto-injector devices (EpiPens) available on-site. The bill establishes a requirement for camps to stock and maintain these emergency medications as part of their safety protocols.

Why is this important

Severe allergic reactions (anaphylaxis) can occur suddenly in children and require immediate epinephrine administration to prevent death or serious injury. Camp settings involve children away from immediate parental oversight and medical facilities, making rapid access to emergency medications critical. This requirement addresses a potential gap in emergency preparedness at facilities serving vulnerable populations.

Potential points of contention

  • Cost and liability concerns: Camps may face expenses for purchasing, storing, and maintaining epinephrine auto-injectors, plus questions about who bears liability if devices are used or malfunction
  • Implementation clarity: The bill may lack specifics on quantities required, staff training requirements, expiration date management, and protocols for device usage and documentation
  • Scope and enforceability: Questions about how requirements apply to smaller or informal camps, whether penalties exist for non-compliance, and which agency enforces standards

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.